Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens
Authors:
- Maarten ElderingMEMaarten Eldering
- Anaïs BompardABAnaïs Bompard
- Kazutoyo MiuraKMKazutoyo Miura
- Will StoneWSWill Stone
- Isabelle MorlaisIMIsabelle Morlais
- Anna CohuetACAnna Cohuet
- Geert-Jan van GemertGGGeert-Jan van Gemert
- Patrick M. BrockPBPatrick M. Brock
- Sanna R. RijpmaSRSanna R. Rijpma
- Marga van de Vegte-BolmerMVMarga van de Vegte-Bolmer
- Wouter GraumansWGWouter Graumans
- Rianne Siebelink-StoterRSRianne Siebelink-Stoter
Open Access
- 17 October 2017
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 10 (1) , 489
Abstract
With the increasing interest in vaccines to interrupt malaria transmission, there is a demand for harmonization of current methods to assess Plasmodium transmission in laboratory settings. Potential vaccine candidates are currently tested in the standard membrane feeding assay (SMFA) that commonly relies on Anopheles stephensi mosquitoes. Other mosquito species including Anopheles gambiae are the dominant malaria vectors for Plasmodium falciparum in sub-Saharan Africa. Using human serum and monoclonal pre-fertilization (anti-Pfs48/45) and post-fertilization (anti-Pfs25) antibodies known to effectively inhibit sporogony, we directly compared SMFA based estimates of transmission-reducing activity (TRA) for An. stephensi and An. gambiae mosquitoes. In the absence of transmission-reducing antibodies, average numbers of oocysts were similar between An. gambiae and An. stephensi. Antibody-mediated TRA was strongly correlated between both mosquito species, and absolute TRA estimates for pre-fertilisation monoclonal antibodies (mAb) showed no significant difference between the two species. TRA estimates for IgG of naturally exposed individuals and partially effective concentrations of anti-Pfs25 mAb were higher for An. stephensi than for An. gambiae. Our findings support the use of An. stephensi in the SMFA for target prioritization. As a vaccine moves through product development, better estimates of TRA and transmission-blocking activity (TBA) may need to be obtained in epidemiologically relevant parasite-species combination.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.158.306)
- Seventh Framework Programme (BE) (242095)
- Malaria Vaccine Initiative
This publication has 53 references indexed in Scilit:
- Transmission-blocking interventions eliminate malaria from laboratory populationsNature Communications, 2013
- Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions?Trends in Parasitology, 2013
- Measuring the blockade of malaria transmission – An analysis of the Standard Membrane Feeding AssayInternational Journal for Parasitology, 2012
- A global map of dominant malaria vectorsParasites & Vectors, 2012
- Mosquito ingestion of antibodies against mosquito midgut microbiota improves conversion of ookinetes to oocysts for Plasmodium falciparum, but not P. yoeliiParasitology International, 2011
- Mosquito immune responses and compatibility between Plasmodium parasites and anopheline mosquitoesBMC Microbiology, 2009
- Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in miceProceedings of the National Academy of Sciences, 2008
- Gene Expression Studies in Mosquitoes2008
- Susceptibility of Anopheles gambiae and Anopheles stephensi to tropical isolates of Plasmodium falciparumMalaria Journal, 2007
- Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigenProceedings of the National Academy of Sciences, 2007